World Health Organization Data on HIV

WHO co-authored a new article published in the AIDS journal focusing on side effects associated with nevirapine and efavirenz, HIV drugs used in first-line antiretroviral therapy. Due to frequent side effects, they can cause significant patient morbidity and are a common cause of drug discontinuation or poor adherence to treatment.

The research reviewed data from eight randomized trials involving adults and children receiving these treatments. The article concludes that efavirenz leads to much lower frequency of side effects compared to nevirapine.

 

The journal article can be accessed here: